ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company has announced the signing of a multi-party coll...
Thermo Fisher Scientific, the world leader in serving science, announced an expansion of its integrated clinical trials ...
The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolme...
Solasia Pharma KK has announced that the darinaparsin Phase 2 study patient registration has reached the targ...
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, on 19 Sep 2019 announced late...
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, has announced that it...
Asia-Pacific specialist CRO Novotech has welcomed the South Korean Comprehensive Five-year Plan for the Advancement of C...
Strekin AG, a biopharmaceutical company focused on treatments for hearing loss, on 12 Sep 2019, announced that it has su...
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicine...
Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical need...
ASLAN Pharmaceuticals a clinical-stage oncology and immunology focused biopharma company, on 27 August 2019, announ...
CStone Pharmaceuticals, on 26 August 2019, announced that the first patient in China has been dosed in Phase I/II b...
Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication i...
CStone Pharmaceuticals, on 23 August 2019, announced that the Company has recently received ethics approval from the Hum...
Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hy...
The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results fr...
AstraZeneca, on 20 August 2019, announced positive results from the landmark Phase III DAPA-HF trial which showed that&n...
CStone Pharmaceuticals, on 13 August 2019, announced the dosing of the first patient in China for the Phase I ...
